生物
造血
祖细胞
干细胞
免疫监视
抗原
抗原呈递
免疫学
细胞生物学
川地34
免疫系统
主要组织相容性复合体
癌症研究
T细胞
作者
Pablo Hernández-Malmierca,Dominik Vonficht,Alexandra Schnell,Hannah J. Uckelmann,Alina Bollhagen,Mohamed A. A. Mahmoud,Sophie-Luise Landua,Elise van der Salm,Christine L. Trautmann,Simon Raffel,Florian Grünschläger,Raphael Lutz,Michael Ghosh,Simon Renders,Nádia Correia,Elisa Donato,Karin O. Dixon,Christoph Hirche,Carolin Andresen,Claudia Robens
出处
期刊:Cell Stem Cell
[Elsevier BV]
日期:2022-05-01
卷期号:29 (5): 760-775.e10
被引量:80
标识
DOI:10.1016/j.stem.2022.04.007
摘要
Hematopoietic stem and progenitor cells (HSPCs) are responsible for the production of blood and immune cells. Throughout life, HSPCs acquire oncogenic aberrations that can cause hematological cancers. Although molecular programs maintaining stem cell integrity have been identified, safety mechanisms eliminating malignant HSPCs from the stem cell pool remain poorly characterized. Here, we show that HSPCs constitutively present antigens via major histocompatibility complex class II. The presentation of immunogenic antigens, as occurring during malignant transformation, triggers bidirectional interactions between HSPCs and antigen-specific CD4+ T cells, causing stem cell proliferation, differentiation, and specific exhaustion of aberrant HSPCs. This immunosurveillance mechanism effectively eliminates transformed HSPCs from the hematopoietic system, thereby preventing leukemia onset. Together, our data reveal a bidirectional interaction between HSPCs and CD4+ T cells, demonstrating that HSPCs are not only passive receivers of immunological signals but also actively engage in adaptive immune responses to safeguard the integrity of the stem cell pool.
科研通智能强力驱动
Strongly Powered by AbleSci AI